Annabelle Volgman to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Annabelle Volgman has written about Adrenergic beta-Antagonists.
Connection Strength
1.042
-
The Role of Angiotensin-Converting Enzyme Inhibitors and ?-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. J Am Heart Assoc. 2020 01 21; 9(2):e015327.
Score: 0.724
-
Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med. 2008 Mar; 5(1):53-61.
Score: 0.318